Skip to main content

Lifevantage Corp

LFVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000849146

In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 1 sale; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Lifevantage Corp changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of LFVN: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders1121107−4
Shares7.38M607.34M−38.9K (−0.5%)
Value$96.5M$785$71.3M−$25.1M (−26.1%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Lifevantage Corp at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to LFVN in Q3 2025
InstitutionSharesValue% of portfolio
SummerHaven Investment Management, LLC68,766$669.1K0.39%
Divisadero Street Capital Management, LP52,900$514.7K0.02%
Navellier & Associates Inc49,354$480.2K0.05%
AQR Capital Management LLC23,304$226.7K0.00%
Advyzon Investment Management, LLC13,955$135.8K0.02%
Jane Street Group, LLC12,692$123.5K0.00%
NFP Retirement, Inc.10,044$97.7K0.01%
Belvedere Trading LLC6,308$61.4K0.00%
Wealthspire Advisors, LLC145$1.41K0.00%
EverSource Wealth Advisors, LLC11$1070.00%
The PNC Financial Services Group, Inc.10$970.00%
Essential Partners LLC2$190.00%

Sold out (16)

Institutions that held Lifevantage Corp at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (1)

Institutions that held Lifevantage Corp at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LFVN in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Financial Gravity Companies, Inc.60$785